Table 2.

Medication Collected by Patients from Pharmacy

Prescription Drugs	All
	n	%
Inhaled COPD medications (6 months prior to COPD measurement)
● LAMAs	147	9.8
● LABAs	33	2.2
● ICS	32	2.1
● LABAs + LAMAs	67	4.5
● LABAs + ICS	281	18.7
● LABAs + LAMAs + ICS	643	42.8
● SABAs	40	2.7
● SABAs and other R03a medication	7	0.5
● Other R03a medication	19	1.3
● No inhaled COPD medication	232	15.5
Other COPD treatments (12 months prior to COPD measurement)
● Respiratory antibioticsb	1044	69.6
● OCS	622	41.4
CVD medication (12 months prior to COPD measurement)
● Anti-dyslipidemics	1040	69.3
● Antihypertensives	1445	96.3
● Antiplatelets	1089	72.6
● Anticoagulants	457	30.4
● Other CV medication	451	30.0
● Diabetes medication	354	23.6

Notes: ^aR03: R03AL01, R03AL02, R03CC02, R03CC03, R03CC12, R03DA04; ^bRespiratory antibiotics: amoxicillin and enzyme inhibitor (ATC-code J01CR02), amoxicillin (J01CA04), pivampicillin (J01CA02), phenoxymethylpenicillin (J01CE02), macrolides (J01FA01, J01FA06, J01FA09, J01FA10).

Abbreviations: COPD, chronic obstructive pulmonary disease; CV, cardiovascular; ICS, inhaled corticosteroids; LABA, long-acting beta-2-agonist; LAMA, long-acting muscarinic antagonist; OCS, oral corticosteroids; SABA, short-acting beta-2-agonist.